QuantLogix ← IDXX scorecard
📅 IDXX Earnings Preview
IDEXX Laboratories, Inc. Common Stock
Next report (est.)
11/03/2026
Countdown
6 days
EPS growth YoY
+17.6%
Revenue growth YoY
+9.7%
Options-implied earnings move
±9.7%
The at-the-money straddle prices a move to roughly $617.27 or $508.07 from $562.67 by 11/20/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/04/2026 ±3.1% +3.6% under-priced
05/05/2026 ±3.1% -0.0% over-priced
02/20/2026 ±3.3% +0.8% over-priced
11/03/2025 ±1.8% +14.8% under-priced
08/04/2025 ±3.0% +27.5% under-priced
05/01/2025 ±2.8% +8.9% under-priced
02/21/2025 ±2.5% -0.0% over-priced
10/31/2024 ±2.0% -9.8% under-priced
Across these reports, options implied an average ±2.7% move vs an actual average of 8.2% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $4.27 $1.2B $338M
Q1 FY2026 $3.47 $1.1B $278M
Q4 FY2025 — $1.1B $248M
Q3 FY2025 $3.40 $1.1B $275M
Analyst posture
Buy / Strong Buy
14
Hold
7
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Neutral · 56/100 Full scorecard →
Get alerted before every IDXX report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on IDXX before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

IDEXX Laboratories, Inc. Common Stock (IDXX) reports in 6 days, with the next report estimated for 11/03/2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 8.2% on average — the market has been roughly fair on IDXX's earnings risk. Fundamentals into the print: EPS up 17.6% year-over-year, revenue up 9.7%. QuantLogix's live 5-factor engine currently reads IDXX as a neutral at 56/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →